HLA-DRB1 and myeloid sarcoma: Genetic studies have consistently confirmed that the MHC class II HLA-DRB1 gene, HLA-DRB1*15:01 is the most important risk factor for the development of MS (44–48), increasing the risk of disease threefold (49).